Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.45
+0.07 (1.30%)
At close: Jul 20, 2026, 4:00 PM EDT
5.46
+0.01 (0.20%)
Pre-market: Jul 21, 2026, 5:00 AM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $149.29 million as of July 21, 2026. Its market cap has increased by 166.60% in one year.
Market Cap
149.29M
Enterprise Value
95.52M
1-Year Change
166.60%
Ranking
Category
Stock Price
$5.45
ChartMarket Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $149.29M, an increase of 124.53%. That is a compound annual growth rate of 17.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 149.29M | 20.39% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 161.91M |
| Milestone Pharmaceuticals | 161.22M |
| PepGen | 155.63M |
| Kazia Therapeutics | 152.43M |
| Connect Biopharma Holdings | 149.85M |
| Pyxis Oncology | 149.52M |
| Molecular Partners AG | 146.99M |
| TuHURA Biosciences | 143.29M |